Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
256,606,920
-
Number of holders
-
390
-
Total 13F shares, excl. options
-
223,473,017
-
Shares change
-
+1,471,279
-
Total reported value, excl. options
-
$15,797,763,300
-
Value change
-
+$100,431,175
-
Put/Call ratio
-
1.55%
-
Number of buys
-
185
-
Number of sells
-
-169
-
Price
-
$70.72
Significant Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q1 2014
457 filings reported holding VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock as of Q1 2014.
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) has 390 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 223,473,017 shares
of 256,606,920 outstanding shares and own 87.09% of the company stock.
Largest 10 shareholders include Capital World Investors (26,739,677 shares), VANGUARD GROUP INC (16,388,650 shares), WELLINGTON MANAGEMENT CO LLP (16,282,460 shares), JENNISON ASSOCIATES LLC (12,604,047 shares), PRICE T ROWE ASSOCIATES INC /MD/ (11,825,010 shares), State Street Corp (10,094,367 shares), AMERIPRISE FINANCIAL INC (8,125,760 shares), JPMORGAN CHASE & CO (7,606,689 shares), Clearbridge Investments, LLC (7,257,377 shares), and FMR LLC (6,608,722 shares).
This table shows the top 390 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.